Abstract
The synthesis of novel phosphatidylcholines with geranic and citronellic acids in sn-1 and sn-2 positions is described. The structured phospholipids were obtained in high yields (59-87%) and evaluated in vitro for their cytotoxic activity against several cancer cell lines of different origin: MV4-11, A-549, MCF-7, LOVO, LOVO/DX, HepG2 and also towards non-cancer cell line BALB/3T3 (normal mice fibroblasts). The phosphatidylcholines modified with monoterpene acid showed a significantly higher antiproliferative activity than free monoterpene acids. The highest activity was observed for the terpene-phospholipids containing the isoprenoid acids in sn-1 position of phosphatidylcholine and palmitic acid in sn-2.
MeSH terms
-
A549 Cells
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Hep G2 Cells
-
Humans
-
Inhibitory Concentration 50
-
MCF-7 Cells
-
Mice
-
Monoterpenes / chemistry
-
NIH 3T3 Cells
-
Organ Specificity
-
Palmitic Acid / chemistry
-
Phosphatidylcholines / chemical synthesis*
-
Phosphatidylcholines / pharmacology
-
Structure-Activity Relationship
-
Terpenes / chemistry
Substances
-
Antineoplastic Agents
-
Monoterpenes
-
Phosphatidylcholines
-
Terpenes
-
Palmitic Acid
Grants and funding
This project was financed by National Science Center of Poland no. 2013/09/D/NZ9/02457. Publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (
http://know.wroc.pl).